Sell insulin while glp1 reps are selling directly against you for same patient type...BRILLIANT!

Discussion in 'Novo Nordisk' started by anonymous, Aug 13, 2019 at 4:18 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Why can ET not see the DCS 1&3 sell directly against the DCS 2. We are going after the same patient type! Spare me the BS of tough insulin pricing, blah blah blah.....how about realize insulin is a commodity, plain and simple. 1 & 3s laughing all the way to the bank, at least saving money on dcs 2s...........but "no layoffs"....yeah, right!
     

  2. anonymous

    anonymous Guest

    I think you should probably understand that you are less influential than you think you are. You can talk patient types all you want, but docs use both glp1 and insulin, and will decide on their own who they use each product for. You’re not competing with anyone except your own ego.
     
  3. anonymous

    anonymous Guest

    Bullshit - the GLP1 reps are telling the doctors to take patients off of insulin with zero regard for the patients well being .
     
  4. anonymous

    anonymous Guest


    What’s your point?
    You’re selling a drug 2x or more expensive than others in the class.

    Sorry, you suck compared to your GLP reps on your team.

    My guess is you were probably a Novolog Rep and were always above 100% to goal, by dropping off portion plates to 30 HCPs.
    Thinking you were just great.

    Time to Produce.
     
  5. anonymous

    anonymous Guest

    Amen! Yes, they are. Sabotaging the business. Hey, Brian, if we didn't get tresiba nbrx greater than 15% with 3 dcs reps selling, wtf are you thinking now with 1 dcs rep and 2 others selling directly against tresiba with o-o-o-ozempic......but you have great glp1 growth.
     
  6. anonymous

    anonymous Guest

    Again, you can tell a doctor what to do all you want. He’s not listening to you. He doesn’t need you to understand which patients benefit from insulin versus GLP-1. These aren’t new classes of medication. He knows way more than you do where to use them. Get over yourself.
     
  7. anonymous

    anonymous Guest


    Exactly right the doctors are going to do what they see fit for the specific patient. Most of the physicians are not yet comfortable with the glp1 class as of yet and it becomes a conversion. Conversation from a garbage insulin to a best in class drug. Forget about who you are selling against and just go out and do your job. There is enough room for us all to eat. Regardless it seems as if we will all be carrying oral in 2020
     
  8. anonymous

    anonymous Guest

    GLP-1 launched more than 10 years ago. Doctors may not use it exactly as the Marketing department wants them to use it, but they are more than comfortable with it. All you do is explain the differences between brands. Doctors decided a long time ago where they want to use this class. You aren’t teaching them anything about patient types...
     
  9. anonymous

    anonymous Guest

    Correct! and who the f@ck do you think you are... trying to the tell the doctor ANYTHING about metabolic syndrome or diabetic etiology?! Your goddamned sales meetings don't mean SHIT against 10 years of medical training!
     
  10. anonymous

    anonymous Guest

    Xultophy is the only answer. Prepare for huge layoff Xmas Eve.
     
  11. anonymous

    anonymous Guest

    Ditto. I find it funny when a sales person with just a bachelors degree in a non-science field wants to educate a doctor with many years of experience.
     
  12. anonymous

    anonymous Guest

    There’s absolutely no need for a primary care insulin sales force anymore. Promote the insulins in the endo space and you will capture over half the potential business with a fraction of the reps. Then focus energies on glp in the pcp world.

    Just my 2 cents.

    Y’all complaining about your coworkers undercutting you are just plain desperate. It has nothing to do with that and everything to do with the fact there are way more options to treat t2d effectively today that don’t involve insulin.
     
  13. anonymous

    anonymous Guest

    What is really funny is the misconception that you and others seem to have that the GLP1 team reps are better sales people ???

    Really - give me a break I’m not sure about you but I could do just as well as most selling ozempic so don’t flatter yourself . You and I and all sales are replaceable
     
  14. anonymous

    anonymous Guest

    Lighten up Francis
     
  15. anonymous

    anonymous Guest

    Yes, we are all replaceable and neither sales force is better. However, the GLP-1 sales force is performing better versus expectations, so they are getting more money. It is what it is.
     
  16. anonymous

    anonymous Guest

    Where is the confusion? Everyone will be selling GLP-1 next year - Brian said it again today. And no lay offs. Stop spreading rumours that are baseless.
     
  17. anonymous

    anonymous Guest

    Does it make sense having a pod of 3 people, HSAM, EDCS all selling the same drug. There might not be layoffs this year because of the oral launch but come next year there will be a huge one. Oh, Dave mentioned last year no layoffs .....
     
  18. anonymous

    anonymous Guest

    No, it doesn’t make sense that 3 people will sell the same products. We’ll call it a reorganization or a mapping exercise, but I can promise you that there will be fewer people working at NNI next year.
     
  19. anonymous

    anonymous Guest

    As if saying “no layoffs” means anything anymore. How many times do you need to be lied to before you quit taking the leaders of this company at their word? They just want to squeeze every little bit of work they can get out of you before they cut you.
     
  20. anonymous

    anonymous Guest

    Truth. The bottom line is, if you find another job with similar benefits, then go for it. Otherwise, enjoy the ride until the car breaks down. Novo has great benefits.